The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
about
Immunotherapy for lung cancerThe use of functional epirubicin liposomes to induce programmed death in refractory breast cancerHuman mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomesTransient Treg depletion enhances therapeutic anti-cancer vaccination.
P2860
The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The efficacy of tumor debulkin ...... using imiquimod and anti-CD40
@ast
The efficacy of tumor debulkin ...... using imiquimod and anti-CD40
@en
type
label
The efficacy of tumor debulkin ...... using imiquimod and anti-CD40
@ast
The efficacy of tumor debulkin ...... using imiquimod and anti-CD40
@en
prefLabel
The efficacy of tumor debulkin ...... using imiquimod and anti-CD40
@ast
The efficacy of tumor debulkin ...... using imiquimod and anti-CD40
@en
P2093
P2860
P356
P1433
P1476
The efficacy of tumor debulkin ...... using imiquimod and anti-CD40
@en
P2093
Amanda L Cleaver
Andrea Khong
Ben C Wylie
Bruce W Robinson
Muhammad Fahmi Alatas
Richard A Lake
Scott A Fisher
Steve Broomfield
Theresa Connor
Willem J Lesterhuis
P2860
P2888
P356
10.1186/1471-2407-14-969
P407
P577
2014-12-17T00:00:00Z
P5875
P6179
1031083727